Pharmacokinetics of Artesunate Self-microemulsion in Rats

Jianjun XI,Jiankang ZHANG,Xuwang PAN,Yanmei ZHAO,Ruoyu HE,Rangxiao ZHUANG,Liyan QIU
DOI: https://doi.org/10.13748/j.cnki.issn1007-7693.2017.03.017
2017-01-01
Abstract:OBJECTIVE To establish a method for determining the plasma concentration of artesunate in rat with LC-MS/MS,and study the pharmacokinetic parameters of artesunate self-microemulsion in rat.METHODS Twelve SD rats were randomly divided into two groups,which were gavaged with a single dose of artesunate self-microemulsion and artesunate API at the concentration of 50 mg·kg-1.Afterwards,the drug plasma concentrations were determined by LC-MS/MS with glipizide as an internal standard,and pharmacokinetic parameters were calculated as well.RESULTS The linear ranges of artesunate was from 1.0 to 1 000 ng.mL-1 with a regression equation:A=294.74C-439.33(r=0.999 6),and the limit of quantitation was 1.0 ng.mL-1.The intraday and inter-day variable coefficients were both <10%,which met the requirements of biological sample analyses.The Cmax,t1/2 and AUC0→t values of artesunate self-microemulsion were (421±41.6)ng.mL-1,(1.48±0.17)h and (282×17.7)h·ng.mL-1 while with values of (87.6×8.80)ng.mL-1,(1.88×0.33)h and (43.3×l.74)h.ng·mL-1 for artesunate API.CONCLUSION The method for evaluating these pharmacokinetic parameters is simple and sensitive,which can be used for determining the content of artesunate in plasma.Besides,the bioavailability of artesunate self-microemulsion in rats is significantly improved after gavage administration compared to that of the artesunate API.
What problem does this paper attempt to address?